Annual ROE
-95.22%
+644.91%+87.13%
December 31, 2023
Summary
- As of February 8, 2025, TENX annual return on equity is -95.22%, with the most recent change of +644.91% (+87.13%) on December 31, 2023.
- During the last 3 years, TENX annual ROE has risen by +117.76% (+55.29%).
- TENX annual ROE is now -102.10% below its all-time high of 4541.16%, reached on April 30, 2012.
Performance
TENX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-46.00%
+77.59%+62.78%
September 30, 2024
Summary
- As of February 8, 2025, TENX quarterly return on equity is -46.00%, with the most recent change of +77.59% (+62.78%) on September 30, 2024.
- Over the past year, TENX quarterly ROE has increased by +43.73% (+48.74%).
- TENX quarterly ROE is now -101.46% below its all-time high of 3147.08%, reached on October 31, 2012.
Performance
TENX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TENX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +87.1% | +48.7% |
| 3 y3 years | +55.3% | +52.5% |
| 5 y5 years | -64.5% | +52.5% |
TENX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +87.5% | at high | +94.3% |
| 5 y | 5-year | at high | +87.5% | at high | +94.3% |
| alltime | all time | -102.1% | +97.7% | -101.5% | +99.5% |
Tenax Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -46.00%(-62.8%) |
| Jun 2024 | - | -123.59%(+37.7%) |
| Mar 2024 | - | -89.73%(+36.4%) |
| Dec 2023 | -95.22%(-87.1%) | -65.79%(-5.8%) |
| Sep 2023 | - | -69.85%(-27.9%) |
| Jun 2023 | - | -96.87%(-34.0%) |
| Mar 2023 | - | -146.87%(-54.0%) |
| Dec 2022 | -740.13%(-3.3%) | -319.38%(+13.1%) |
| Sep 2022 | - | -282.35%(+11.4%) |
| Jun 2022 | - | -253.44%(-19.4%) |
| Mar 2022 | - | -314.48%(-61.1%) |
| Dec 2021 | -765.06%(+259.2%) | -809.32%(+3.6%) |
| Sep 2021 | - | -781.29%(+6.2%) |
| Jun 2021 | - | -735.48%(+7.9%) |
| Mar 2021 | - | -681.82%(+219.7%) |
| Dec 2020 | -212.98%(-4.3%) | -213.26%(-4.2%) |
| Sep 2020 | - | -222.72%(-5.0%) |
| Jun 2020 | - | -234.33%(+38.8%) |
| Mar 2020 | - | -168.81%(+47.1%) |
| Dec 2019 | -222.52%(+284.5%) | -114.72%(+36.7%) |
| Sep 2019 | - | -83.93%(+4.9%) |
| Jun 2019 | - | -79.98%(-8.1%) |
| Mar 2019 | - | -86.99%(-1.2%) |
| Dec 2018 | -57.88%(-41.8%) | -88.08%(+4.0%) |
| Sep 2018 | - | -84.70%(+25.0%) |
| Jun 2018 | - | -67.77%(-3.9%) |
| Mar 2018 | - | -70.55%(-11.4%) |
| Dec 2017 | -99.52%(-61.2%) | -79.59%(-71.8%) |
| Sep 2017 | - | -282.01%(+56.5%) |
| Jun 2017 | - | -180.17%(+38.7%) |
| Mar 2017 | - | -129.89%(+25.7%) |
| Dec 2016 | -256.25%(+1438.1%) | -103.31%(+268.8%) |
| Sep 2016 | - | -28.01%(-3.4%) |
| Jun 2016 | - | -29.00%(+21.5%) |
| Mar 2016 | - | -23.86%(-18.5%) |
| Dec 2015 | -16.66%(-9.3%) | - |
| Oct 2015 | - | -29.27%(+24.2%) |
| Sep 2015 | - | -23.57%(-4.2%) |
| Jul 2015 | - | -24.60%(+28.5%) |
| Apr 2015 | -18.37%(-61.9%) | -19.15%(+24.4%) |
| Mar 2015 | - | -15.40%(-45.1%) |
| Jan 2015 | - | -28.06%(-22.8%) |
| Oct 2014 | - | -36.33%(-25.8%) |
| Jul 2014 | - | -48.99%(-42.1%) |
| Apr 2014 | -48.19%(-109.1%) | -84.68%(-52.4%) |
| Jan 2014 | - | -177.75%(-98.1%) |
| Oct 2013 | - | -9199.23%(-756.9%) |
| Jul 2013 | - | 1400.32%(+51.5%) |
| Apr 2013 | 529.57%(-88.3%) | 924.27%(-40.0%) |
| Jan 2013 | - | 1539.46%(-51.1%) |
| Oct 2012 | - | 3147.08%(+167.3%) |
| Jul 2012 | - | 1177.43%(+22.9%) |
| Apr 2012 | 4541.16% | 957.90%(+49.3%) |
| Jan 2012 | - | 641.77%(+42.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2011 | - | 449.46%(-49.8%) |
| Jul 2011 | - | 895.54%(-147.6%) |
| Apr 2011 | 280.53%(-169.8%) | -1882.66%(+275.2%) |
| Jan 2011 | - | -501.81%(+69.0%) |
| Oct 2010 | - | -296.88%(+4.4%) |
| Jul 2010 | - | -284.33%(+2.9%) |
| Apr 2010 | -401.93%(-22.2%) | -276.41%(-46.9%) |
| Jan 2010 | - | -520.42%(-0.8%) |
| Oct 2009 | - | -524.51%(+7.8%) |
| Jul 2009 | - | -486.39%(+13.1%) |
| Apr 2009 | -516.89%(+274.1%) | -429.88%(+59.1%) |
| Jan 2009 | - | -270.16%(+12.0%) |
| Oct 2008 | - | -241.29%(-18.1%) |
| Jul 2008 | - | -294.65%(-41.7%) |
| Apr 2008 | -138.17%(-96.6%) | -505.09%(-173.6%) |
| Jan 2008 | - | 686.51%(+15.9%) |
| Oct 2007 | - | 592.26%(-51.8%) |
| Jul 2007 | - | 1229.50%(-58.2%) |
| Apr 2007 | -4084.35%(+469.8%) | 2941.19%(-164.1%) |
| Jan 2007 | - | -4590.56%(+352.6%) |
| Oct 2006 | - | -1014.24%(+85.9%) |
| Jul 2006 | - | -545.66%(+32.9%) |
| Apr 2006 | -716.82%(+128.3%) | -410.71%(+32.2%) |
| Jan 2006 | - | -310.74%(-4.4%) |
| Oct 2005 | - | -324.96%(+30.8%) |
| Jul 2005 | - | -248.39%(-17.7%) |
| Apr 2005 | -313.95%(+15.5%) | -301.77%(+12.5%) |
| Jan 2005 | - | -268.27%(-4.3%) |
| Oct 2004 | - | -280.35%(+8.2%) |
| Jul 2004 | - | -259.04%(+0.7%) |
| Apr 2004 | -271.86%(+143.9%) | -257.33%(+21.1%) |
| Jan 2004 | - | -212.41%(+33.2%) |
| Oct 2003 | - | -159.45%(-2.7%) |
| Jul 2003 | - | -163.92%(+41.3%) |
| Apr 2003 | -111.45%(+21.3%) | -116.02%(-27.3%) |
| Jan 2003 | - | -159.55%(+21.3%) |
| Oct 2002 | - | -131.54%(+35.8%) |
| Jul 2002 | - | -96.84%(+6.6%) |
| Apr 2002 | -91.85%(+184.3%) | -90.81%(+88.7%) |
| Jan 2002 | - | -48.13%(+13.0%) |
| Oct 2001 | - | -42.59%(+8.5%) |
| Jul 2001 | - | -39.25%(+22.9%) |
| Apr 2001 | -32.31%(+2.0%) | -31.94%(-7.3%) |
| Jan 2001 | - | -34.46%(-10.9%) |
| Oct 2000 | - | -38.68%(-11.8%) |
| Jul 2000 | - | -43.84%(-27.7%) |
| Apr 2000 | -31.68%(-95.0%) | -60.61%(-120.2%) |
| Jan 2000 | - | 300.00%(+50.0%) |
| Oct 1999 | - | 200.00%(+300.0%) |
| Jul 1999 | - | 50.00% |
| Apr 1999 | -636.05%(+74.6%) | - |
| Apr 1998 | -364.33%(-153.9%) | - |
| Apr 1997 | 676.25%(+72.2%) | - |
| Apr 1996 | 392.60% | - |
FAQ
- What is Tenax Therapeutics annual return on equity?
- What is the all time high annual ROE for Tenax Therapeutics?
- What is Tenax Therapeutics annual ROE year-on-year change?
- What is Tenax Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly ROE year-on-year change?
What is Tenax Therapeutics annual return on equity?
The current annual ROE of TENX is -95.22%
What is the all time high annual ROE for Tenax Therapeutics?
Tenax Therapeutics all-time high annual return on equity is 4541.16%
What is Tenax Therapeutics annual ROE year-on-year change?
Over the past year, TENX annual return on equity has changed by +644.91% (+87.13%)
What is Tenax Therapeutics quarterly return on equity?
The current quarterly ROE of TENX is -46.00%
What is the all time high quarterly ROE for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly return on equity is 3147.08%
What is Tenax Therapeutics quarterly ROE year-on-year change?
Over the past year, TENX quarterly return on equity has changed by +43.73% (+48.74%)